Please ensure Javascript is enabled for purposes of website accessibility
Don't miss
Home / News / Local / J&J misled Pennsylvania on drug’s risks, lawyer says

J&J misled Pennsylvania on drug’s risks, lawyer says

A Johnson & Johnson unit misled Pennsylvania officials about the health risks of its Risperdal anti-psychotic drug and duped the state into paying $289 million more than it should have for the medicine, a lawyer said. Pennsylvania officials wouldn't have paid a premium for Risperdal had they known it was no more effective than existing anti-psychotic ...